Phase Ib trial of ALT-803, an IL-15 superagonist, plus BCG for the treatment of BCG-naive patients with non-muscle-invasive bladder cancer.

被引:11
|
作者
Rosser, Charles Joel
Nix, Jeffrey
Ferguson, Lydia
Hernandez, Liza
Wong, Hing C.
机构
[1] Univ Hawaii Canc Ctr, Honolulu, HI USA
[2] Univ Alabama Birmingham, Birmingham, AL USA
[3] Altor BioScience, Miramar, FL USA
关键词
D O I
10.1200/JCO.2018.36.6_suppl.510
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
510
引用
收藏
页数:2
相关论文
共 50 条
  • [11] The significance of protocol biopsy after intravesical BCG treatment in patients with non-muscle-invasive bladder cancer.
    Maruyama, Satoru
    Shinohara, Nobuo
    Murahashi, Norihiro
    Suzuki, Hidetaka
    Matsumoto, Ryuji
    Akino, Tomoshige
    Miyajima, Naoto
    Tsuchiya, Kunihiko
    Abe, Takashige
    Nonomura, Katsuya
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [12] Preliminary phase 2 clinical results of IL-15RαFc superagonist N-803 with BCG in BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) patients.
    Chamie, Karim
    Lee, John H.
    Rock, Amy
    Rhode, Peter R.
    Soon-Shiong, Patrick
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [13] Quality of life in QUILT 3.032 study: Patients with BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) receiving IL-15RaFc superagonist N-803 plus BCG.
    Chamie, Karim
    Chang, Sam S.
    Kramolowsky, Eugene V.
    Gonzalgo, Mark L.
    Lechpammer, Stanislav
    Reddy, Sandeep K.
    Soon-Shiong, Patrick
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [14] Effectiveness of two different dose administration regimens of an IL-15 superagonist complex (ALT-803) in an orthotopic bladder cancer mouse model
    Hideki Furuya
    Owen T. M. Chan
    Ian Pagano
    Chengjun Zhu
    Nari Kim
    Rafael Peres
    Kanani Hokutan
    Sarah Alter
    Peter Rhode
    Charles J. Rosser
    Journal of Translational Medicine, 17
  • [15] Effectiveness of two different dose administration regimens of an IL-15 superagonist complex (ALT-803) in an orthotopic bladder cancer mouse model
    Furuya, Hideki
    Chan, Owen T. M.
    Pagano, Ian
    Zhu, Chengjun
    Kim, Nari
    Peres, Rafael
    Hokutan, Kanani
    Alter, Sarah
    Rhode, Peter
    Rosser, Charles J.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2019, 17 (1)
  • [16] First results of the phase Ib-II BladderGATE clinical trial: intravenous atezolizumab plus intravesical bacillus Calmette-Guerin (BCG) upfront combination in BCG-naive high risk non-muscle invasive bladder cancer patients
    Guerrero-Ramos, F.
    De Velasco, G.
    Duenas, M.
    Paramio, J.
    Garcia, V. M.
    Gomez-Canizo, C.
    Rodriguez-Izquierdo, M.
    Hernandez-Arroyo, M.
    Martin-Torres, M. P.
    Alvarez-Rodriguez, P.
    Suarez, C.
    Morales, L.
    Ponce, S.
    Rodriguez-Antolin, A.
    Castellano, D.
    EUROPEAN UROLOGY, 2024, 85 : S1701 - S1701
  • [17] FINAL CLINICAL RESULTS OF PIVOTAL TRIAL OF IL-15RAFC SUPERAGONIST N-803 WITH BCG IN BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) CIS AND PAPILLARY COHORTS
    Chang, Sam
    Chamie, Karim
    Hidalgo, Mark
    Kramolowsky, Eugene
    Sexton, Wade
    Reddy, Sandeep
    Soon-Shiong, Patrick
    JOURNAL OF UROLOGY, 2022, 207 (05): : E1047 - E1047
  • [18] Treatment options in non-muscle-invasive bladder cancer after BCG failure
    Brooks, Nathan A.
    O'Donnell, Michael A.
    INDIAN JOURNAL OF UROLOGY, 2015, 31 (04) : 312 - 319
  • [19] Association of BCG Vaccine Treatment With Death and Dementia in Patients With Non-Muscle-Invasive Bladder Cancer
    Weinberg, Marc S.
    Zafar, Affan
    Magdamo, Colin
    Chung, Sun Young
    Chou, Wesley H.
    Nayan, Madhur
    Deodhar, Mayuresh
    Frendl, Daniel M.
    Feldman, Adam S.
    Faustman, Denise L.
    Arnold, Steven E.
    Vakulenko-Lagun, Bella
    Das, Sudeshna
    JAMA NETWORK OPEN, 2023, 6 (05) : E2314336
  • [20] OUTCOMES OF PATIENTS TREATED WITH ADDITIONAL BCG FOLLOWING A BCG UNRESPONSIVE NON-MUSCLE-INVASIVE BLADDER CANCER DIAGNOSIS
    Christopher, Guske
    Joshua, Linscott
    Christian, Harrs
    Pierre, Ghobrial
    Daniel, Calkins
    Barry, Sirard R.
    Behzad, Jazayeri
    Lexiaochuan, Wen
    Justin, Miller
    Xu, Hongzhi
    Logan, Zemp
    Alice, Yu
    Scott, Gilbert
    Michael, Poch
    Philippe, Spiess
    Wade, Sexton
    Roger, Li
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2025, 43 (03)